DelveInsight’s ‘Major Depressive Disorder (MDD)- Epidemiology Forecast-2028’ report delivers an in-depth understanding of the disease, historical & forecasted epidemiology of MDD in the 7 Major Markets (MM) i.e., United States, EU5 (Germany, Spain, Italy, France and United Kingdom) and Japan.
Geography Covered
• The United States
• EU5 (Germany, France, Italy, Spain and the United Kingdom)
• Japan
Study Period: 2017-2028
Major Depressive Disorder (MDD) - Disease Understanding
The DelveInsight Major Depressive Disorder epidemiology report gives the thorough understanding of the MDD by including details such as disease definition, classification, symptoms, risk factors, pathogenesis, and diagnostic trends. It also provides treatment algorithms and treatment guidelines for Major Depressive Disorder in the 7 Major Markets (MM), i.e., United States, EU5 (Germany, Spain, Italy, France and United Kingdom) and Japan. Major depressive disorder is the most prevalent and disabling form of depression. In addition to the immediate symptoms of depression, MDD results in poor quality of life overall, decreased productivity, and affects females more than males. MDD is one form of depressive illness, or mood disorder. Other forms include bipolar disorder (manic-depressive illness) and dysthymia.
Major Depressive Disorder (MDD) Epidemiology
The Major Depressive Disorder (MDD) epidemiology division provide the insights about historical and current patient pool and forecasted trend for every 7 major markets. The epidemiology data for Major Depressive Disorder epidemiology are studied through all possible division to give a better understanding about the Disease scenario in 7MM. It also helps to recognize the causes of current and forecasted trends by exploring numerous studies, survey reports and views of key opinion leaders.
Major Depressive Disorder Epidemiology Segmentation
The disease epidemiology covered in the report provides historical as well as forecasted epidemiology (12 months prevalent cases of Major Depressive Disorder, age-specific cases of Major Depressive Disorder, gender-specific cases of Major Depressive Disorder, severity-specific cases of Major Depressive Disorder, treatable cases of Major Depressive Disorder, relapsed/refractory cases of Major Depressive Disorder) scenario of Major Depressive Disorder (MDD) in the 7MM covering United States, EU5 (Germany, Spain, Italy, France and United Kingdom) and Japan from 2017-2028.
The DelveInsight report also provides the epidemiology trends observed in the 7MM during the study period, along with the assumptions undertaken. The calculated data are presented with relevant tables and graphs to give a clear view of the epidemiology at first sight.
According to DelveInsight, total 12 months prevalent population of Major Depressive Disorder in 7 major markets was observed to be 34,011,712 cases in 2017.
Report Scope
• The report covers the descriptive overview of Major Depressive Disorder, explaining its causes and currently available therapies
• Comprehensive insight has been provided into the epidemiology of the Major Depressive Disorder and its treatment in the 7 MM, covering the United States, EU5 (Germany, Spain, France, Italy, the UK) & Japan
• Additionally, an all-inclusive account of both the current and emerging therapies for Major Depressive Disorder are provided, along with assessment of the impact new therapies will have on the current treatment landscape
• A detailed review of global historical and forecasted Major Depressive Disorder market is included in the report, covering drug outreach in 7 MM
• The report provides an edge while developing business strategies, by understanding trends shaping and driving the global Major Depressive Disorder market
Major Depressive Disorder Report Key Strengths
• 9 Years Forecast
• 7MM Coverage
• Epidemiology Segmentation
• Key Cross Competition
• Market Size by Therapies
• Drugs Uptake
Major Depressive Disorder Epidemiology Segmentation
• 12 months prevalent cases of Major Depressive Disorder
• Age-specific cases of Major Depressive Disorder in 7 MM
• Gender-specific cases of Major Depressive Disorder, in 7 MM
• Severity-specific cases of Major Depressive Disorder in 7 MM
• Treatable cases of Major Depressive in 7 MM
• Relapsed/refractory cases of Major Depressive Disorder in 7 MM
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook